Volastra Therapeutics
Volastra Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 5 tracked investors.
About Volastra Therapeutics
Based in the United States, Volastra Therapeutics is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
Volastra Therapeutics is a clinical-stage biotechnology company focused on developing oncology therapeutics that target chromosomal instability (CIN) in cancer cells. The company exploits vulnerabilities in chromosomally unstable cancers through synthetic lethality and immune activation approaches.
Explore Volastra Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.